We are live on ! Find out more
TGTX icon

TG Therapeutics
TGTX

91 hedge funds and large institutions have $178M invested in TG Therapeutics in 2016 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 10

26% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 23

12% more funds holding

Funds holding: 81 → 91 (+10)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

29% less capital invested

Capital invested by funds: $250M → $178M (-$71.2M)

88% less call options, than puts

Call options by funds: $115K | Put options by funds: $962K

Holders
91
Holders Change
+10
Holders Change %
+12.35%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
20
Increased
29
Reduced
23
Closed
10
Calls
$115K
Puts
$962K
Net Calls
-$847K
Net Calls Change
+$63K

Top Buyers

Rank Fund Capital Flow
1
BM
Bridger Management
New York
+$15.1M
2
PAMU
Pictet Asset Management (UK)
United Kingdom
+$8.72M
3
Millennium Management
Millennium Management
New York
+$1.61M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.24M
5
CS
Credit Suisse
Switzerland
+$1.24M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$13M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$9.48M
3
State Street
State Street
Massachusetts
-$4.53M
4
VAM
Visium Asset Management
New York
-$4.47M
5
OM
Opaleye Management
Massachusetts
-$1.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$701K +$22.7K +2,788 +2%
NFA
27
Nationwide Fund Advisors
Ohio
$660K +$704K +86,573 +388%
ARTA
28
A.R.T. Advisors
New York
$537K +$721K +88,654 New
OAM
29
Oxford Asset Management
United Kingdom
$475K +$638K +78,427 New
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$468K -$24.5K -3,012 -4%
FAM
31
Fred Alger Management
New York
$413K – – –
Swiss National Bank
32
Swiss National Bank
Switzerland
$404K +$80.5K +9,900 +17%
Deutsche Bank
33
Deutsche Bank
Germany
$397K +$95K +11,688 +22%
AllianceBernstein
34
AllianceBernstein
Tennessee
$371K +$126K +15,500 +34%
Charles Schwab
35
Charles Schwab
California
$358K – – –
TA
36
Teachers Advisors
New York
$343K +$24.1K +2,961 +6%
Morgan Stanley
37
Morgan Stanley
New York
$309K -$168K -20,703 -29%
Citadel Advisors
38
Citadel Advisors
Florida
$267K +$358K +44,001 New
TI
39
Trexquant Investment
Connecticut
$264K +$355K +43,609 New
VKH
40
Virtu KCG Holdings
New York
$263K +$352K +43,326 New
Royal London Asset Management
41
Royal London Asset Management
United Kingdom
$261K +$351K +43,133 New
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$228K +$25.3K +3,107 +9%
VEA
43
Virtus ETF Advisers
New York
$214K +$91.9K +11,311 +47%
Creative Planning
44
Creative Planning
Kansas
$195K – – –
EA
45
Emerald Acquisition
Washington
$190K +$254K +31,272 New
SCA
46
Secor Capital Advisors
New York
$187K +$251K +30,820 New
WMSA
47
Weiss Multi-Strategy Advisers
New York
$185K -$166K -20,400 -40%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$182K -$713K -87,688 -74%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$159K +$24.8K +3,053 +13%
MLICM
50
Metropolitan Life Insurance Company (MetLife)
New York
$154K – – –
1
2
3 4

TGTX Hedge Fund Activity: Q2 2016 in Review

91 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q2 2016, worth a combined $178M — down 29% from $250M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TGTX positions and 10 closed out — a net gain of 10 holders — while 29 added to existing stakes and 23 trimmed.

The largest buyer was Bridger Management, adding an estimated $15.1M. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $13M sold.

  • 91 institutional investors held TG Therapeutics (TGTX) as of Q2 2016, up from 81 in Q1 2016.
  • Funds reported $178M of TG Therapeutics stock for Q2 2016, down 29% quarter-over-quarter.
  • 20 funds opened new TG Therapeutics positions in Q2 2016 and 10 closed out, a net change of +10 holders.
  • The largest TG Therapeutics buyer in Q2 2016 was Bridger Management, an estimated $15.1M added.
  • The largest TG Therapeutics seller in Q2 2016 was Sectoral Asset Management, an estimated $13M sold.

Based on aggregated 13F filings for Q2 2016.